News Sentiment

VCEL sentiment intelligence

Vericel Corp Ord news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 50 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 40.10 Week of 19 Jun 2026
Weighted tone 55/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

77/100 classification confidence.

Company focus 43

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+7.0% over one week, +15.5% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Vericel (VCEL) Stock Could Be 37.3% Undervalued After Earnings Beat And Fund Buying

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 77/100 classification
One-week reaction 7.0% Price confirming higher
Trend fit Trend inactive 15.5% over four weeks
Fair value -3.2% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 29
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 43
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 12
Market source 11
simplywall.st 5
TradingKey 5
ChartMill 3
TradingView 3
MarketBeat 2
The Globe and Mail 1

Event Lens

What the news is about

Classified themes
Earnings 23
Market update 23
Capital return 1
Analyst action 1
Balance sheet 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 50
Stock Titan Direct company coverage

[144] Vericel Corp SEC Filing

This article reports a Form 144 SEC filing by Vericel Corp (VCEL) on June 18, 2026, indicating a proposed sale of 15,000 shares of common stock acquired through a stock option exercise, valued at $603,148.23. The filing details the transaction and confirms no prior sales within t

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 20:40
Source
Stock Titan
TradingKey Direct company coverage

Vericel Corp (VCEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Vericel Corp (VCEL) by business segment and region. As of FY2024, the company's revenue heavily relies on its MACI product (86.70%), followed by Epicel (11.61%) and NexoBrid (1.70%). All reported revenue originates from the U

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 09:40
Source
TradingKey
TradingKey Direct company coverage

Vericel Corp (VCEL) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Vericel Corp (VCEL), outlining both major individual shareholders and the types of institutional investors holding its stock. It provides a breakdown of proportional holdings by firms like BlackRock, State Street, and Vanguard, al

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 01:39
Source
TradingKey
TradingKey Direct company coverage

Vericel Corp (VCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Vericel Corp (VCEL)'s dividend and stock split history. It notes that the company has not distributed any dividends over the past five years and has no recorded stock splits. The page also displays current stock information such as market cap

Tone
Neutral 50/100
Event
Capital return
Published
18 Jun 2026 00:39
Source
TradingKey
TradingKey Direct company coverage

Vericel Corp (VCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates

Vericel Corp (VCEL) has an earnings forecast score of 8.50, ranking 34th in the Pharmaceuticals industry. Analysts have an average price target of $55.00 for VCEL, with the majority recommending a "Buy" trend. The company's expected revenue for the next quarter is $72.69 million,

Tone
Positive 75/100
Event
Earnings
Published
17 Jun 2026 01:10
Source
TradingKey
TradingKey Direct company coverage

Vericel Corp (VCEL) Institutional Confidence

Vericel Corp (VCEL) has a high institutional shareholding score of 10.00, placing it first in the Pharmaceuticals industry. Institutional shareholding has increased by 11.74% quarter-over-quarter, with BlackRock and State Street being among the top institutional holders. Steven C

Tone
Positive 74/100
Event
Market update
Published
17 Jun 2026 01:10
Source
TradingKey
The Globe and Mail Direct company coverage

Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Vericel (VCEL)

This article provides an overview of analyst ratings for two healthcare companies, Rezolute (RZLT) and Vericel (VCEL). Douglas Tsao from H.C. Wainwright reiterated a Buy rating for Rezolute with a $5.00 price target, while Josh Jennings from TD Cowen reiterated a Buy rating for V

Tone
Positive 73/100
Event
Analyst action
Published
11 Jun 2026 11:09
Source
The Globe and Mail
Stock Titan Direct company coverage

How to watch Vericel's June 16 Truist MedTech talk online

Vericel (NASDAQ: VCEL) announced it will present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026. A live webcast of the presentation will be accessible through the Investor Relations section of Vericel's website. The company's stock saw a 4.14% gain on

Tone
Neutral 50/100
Event
Market update
Published
09 Jun 2026 23:39
Source
Stock Titan
Market source Direct company coverage

Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026

Vericel Corporation announced it will present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026. A webcast of the presentation will be available on the Investor Relations section of the Company's website. Vericel is a leader in advanced therapies for spor

Tone
Positive 59/100
Event
Market update
Published
09 Jun 2026 12:08
Source
Market source
Stock Titan Direct company coverage

Vericel (VCEL) CMO sells 4,375 shares after option exercise

Vericel Corp's Chief Medical Officer, Jonathan Mark Hopper, exercised stock options for 4,375 shares at $16.66 per share and simultaneously sold those 4,375 shares at $35.00 per share. These transactions were executed automatically under a pre-arranged Rule 10b5-1 trading plan. A

Tone
Neutral 50/100
Event
Market update
Published
04 Jun 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Proposed sale of 4,375 VCEL shares (NASDAQ: VCEL)

A recently filed Form 144 by Vericel Corp (VCEL) indicates a proposed sale of 4,375 shares of common stock by Fidelity Brokerage Services LLC, dated June 2, 2026, described as an "option-related sale with cash proceeds." The filing also notes a past sale by Jonathan M. Hopper of

Tone
Neutral 50/100
Event
Balance sheet
Published
02 Jun 2026 18:51
Source
Stock Titan
Market source Direct company coverage

Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More

Soleus Capital Management recently bought an additional 1.785 million shares of Vericel (NASDAQ:VCEL), an estimated $63.40 million investment. Despite recent struggles in its stock price, Vericel's revenue climbed 20% year over year, with gross margins expanding and adjusted EBIT

Tone
Neutral 50/100
Event
Earnings
Published
30 May 2026 18:59
Source
Market source
Stock Titan Direct company coverage

Vericel (VCEL) amends bylaws to reflect new Burlington, MA global headquarters

Vericel Corporation (VCEL) has amended its corporate bylaws to reflect its new global headquarters located at 25 Blue Sky Drive, Burlington, Massachusetts 01803. The amendment was approved by the Board of Directors and became effective on May 18, 2026. This change ensures that th

Tone
Neutral 50/100
Event
Market update
Published
19 May 2026 20:10
Source
Stock Titan
MarketBeat Direct company coverage

Vericel Corporation $VCEL Stock Position Reduced by Truist Financial Corp

Truist Financial Corp reduced its stake in Vericel Corporation ($VCEL) by 59.9% in the fourth quarter, selling 37,035 shares and retaining 24,763 shares valued at approximately $892,000. Despite this reduction, other institutional investors increased their positions, and Vericel'

Tone
Neutral 50/100
Event
Earnings
Published
18 May 2026 11:09
Source
MarketBeat
Stock Titan Direct company coverage

Vericel (VCEL) director McLaughlin exercises options and sells 7,000 shares

Vericel Corp director Kevin F. McLaughlin exercised stock options to acquire 7,000 shares and subsequently sold all 7,000 shares in open-market transactions on May 13, 2026. The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2025. After these

Tone
Neutral 50/100
Event
Market update
Published
15 May 2026 20:13
Source
Stock Titan
Investing.com Nigeria Direct company coverage

Vericel director Paul Wotton sells $327,425 in company stock By Investing.com

Paul K. Wotton, a director at Vericel Corp, sold 10,000 shares of the company's common stock for a total of $327,425 on May 11, 2026. The stock traded between $32.64 and $33.05 per share, and following the sale, Wotton directly holds 18,802 shares. Despite a recent decline of ove

Tone
Neutral 50/100
Event
Market update
Published
14 May 2026 11:10
Source
Investing.com Nigeria
Investing.com Direct company coverage

Vericel director Paul Wotton sells $327,425 in company stock

Vericel director Paul Wotton sold 10,000 shares of Vericel Corp (NASDAQ:VCEL) common stock for $327,425 on May 11, 2026, with the shares trading between $32.64 and $33.05. Despite this sale and a recent stock decline, InvestingPro suggests the company is undervalued. Vericel also

Tone
Neutral 50/100
Event
Market update
Published
13 May 2026 20:39
Source
Investing.com
Stock Titan Direct company coverage

Director Paul K. Wotton sells 10,000 Vericel (VCEL) shares around $33

Vericel director Paul K. Wotton sold a total of 10,000 shares of common stock in open-market transactions on May 11, 2026. The sales were executed in two separate transactions at prices of $32.64 and $33.05 per share, amounting to a net sale of $327,425. Following these transacti

Tone
Negative 30/100
Event
Market update
Published
13 May 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Issuer (NASDAQ: VCEL) notifies sale of 7,000 common shares

Vericel Corporation (NASDAQ: VCEL) has filed a Form 144 notice to sell 7,000 shares of common stock through Fidelity Brokerage Services LLC on May 13, 2026. These shares originate from two option grants issued in 2017 and 2018, each for 3,500 shares. The filing is a regulatory in

Tone
Neutral 50/100
Event
Regulatory and legal
Published
13 May 2026 18:09
Source
Stock Titan
Insider Monkey Direct company coverage

Vericel Corporation (NASDAQ:VCEL) Q1 2026 Earnings Call Transcript

Vericel Corporation (NASDAQ:VCEL) reported a strong Q1 2026, with total revenue exceeding $68 million, a 30% increase year-over-year, driven by substantial growth in both MACI and the Burn Care business. The company raised its full-year 2026 revenue guidance by $10 million to a r

Tone
Positive 87/100
Event
Earnings
Published
09 May 2026 12:39
Source
Insider Monkey
GuruFocus Direct company coverage

Insider Sell: Mara Joseph Anthony Jr Sells 5,000 Shares of Veric

Mara Joseph Anthony Jr, CFO of Vericel Corp (VCEL), recently sold 5,000 shares, reducing his holdings to 21,009 shares. Over the past year, there have been 17 insider sells and no insider buys at Vericel. The stock, trading at $40.50, is considered significantly undervalued again

Tone
Negative 39/100
Event
Market update
Published
09 May 2026 00:10
Source
GuruFocus